Soliman will present the reasoning behind the update to the systematic review and guidelines. She will describe the advances in review methods e.g., risk of bias assessments and GRADE processes to explain how data has been robustly and objectively synthesised from primary research. She will also present the findings in relation to the pharmacological treatment of neuropathic pain.